Weiss Lawrence Martin 4
4 · NEOGENOMICS INC · Filed Mar 3, 2021
Insider Transaction Report
Form 4
Weiss Lawrence Martin
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-03-02$53.17/sh+29,895$1,589,517→ 29,895 totalExercise: $53.17Exp: 2028-03-02→ Common Stock (29,895 underlying) - Award
Common Stock
2021-03-02+5,276→ 105,797 total
Holdings
- 27,017
Stock Option (Right to Buy)
Exercise: $19.60Exp: 2024-03-01→ Common Stock (27,017 underlying) - 6,667
Stock Option (Right to Buy)
Exercise: $9.22Exp: 2023-04-19→ Common Stock (6,667 underlying) - 8,334
Stock Option (Right to Buy)
Exercise: $13.87Exp: 2023-12-12→ Common Stock (8,334 underlying) - 37,514
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (37,514 underlying)
Footnotes (5)
- [F1]On April 19, 2018, Dr. Weiss was granted 20,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F2]On December 12, 2018, Dr. Weiss was granted 25,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F3]On March 1, 2019, Dr. Weiss was granted 36,022 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F4]On March 2, 2020, Dr. Weiss was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 2, 2021, Dr. Weiss was granted 29,895 stock options. These options vest ratably over the first four anniversary dates of the grant date.